1, butylphthalide is a non-medical insurance drug;

2. Patients need to bear their own expenses when purchasing;

3. The hospital or pharmacy will not reimburse it because it is self-funded medicine;

4. Patients should use it reasonably under the guidance of doctors to avoid unnecessary economic burden.

Drug classification of butylphthalide:

1. pharmacological action: butylphthalide is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects;

2, indications: mainly used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and other diseases;

3. Drug dosage form: Butylphthalide is commonly used in tablets, capsules, suppositories and injections;

4, medication guidance: when using butylphthalide, you need to follow the doctor's advice, pay attention to the dosage and medication time, as well as possible side effects and contraindications.

To sum up, butylphthalide, as a non-medical insurance drug, must be purchased by patients at their own expense. It can not be reimbursed by hospitals or pharmacies, but also needs to be used cautiously under the guidance of doctors to avoid unnecessary economic pressure, ensure drug safety and reasonably control personal medical expenses.

Legal basis:

National basic medical insurance drug list

not have

The National Catalogue of Drugs for Basic Medical Insurance contains some commonly used drugs that are suitable for basic medical needs and have sufficient supply. The drugs in the catalogue are divided into Chinese patent medicine, western medicine and Chinese herbal pieces, and can be divided into class A and class B according to the categories.